Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Accepted on 21 Feb 2025

Exploring Therapeutic Applications of PTEN, TMPRSS2: ERG Fusion, and Tumour Molecular Subtypes in Prostate Cancer Management

in Cancer Molecular Targets and Therapeutics

Fidelis Charles Bugoye
Rispah Torrorey Sawe
Richard Biegon
Nazima Dharsee
Fidelice Mafumiko
Henry Kibona
Said Aboud
Kirtika Patel
Simeon Kipkoech Mining

Frontiers in Oncology

doi 10.3389/fonc.2025.1521204

Editorial

Accepted on 21 Feb 2025

Editorial: Molecular Mechanisms and Therapeutic Targets of Cancer Metastasis and Therapy Resistance

in Cancer Molecular Targets and Therapeutics

Ya-Wen Wang
Xu Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1571403

Review

Accepted on 19 Feb 2025

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies 1

in Cancer Molecular Targets and Therapeutics

Meiqi Miao
Xinxin Liu
Han Zhang
Hai-Long Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1516977

Mini Review

Accepted on 18 Feb 2025

From Tissue-Specific to Tissue-Agnostic: HER2 Overexpression and the Rise of Antibody-Drug Conjugates

in Cancer Molecular Targets and Therapeutics

Heidi C Ko
Kyle C Strickland
Dana Jaggessarsingh
Alicia Dillard
Michelle Green
Erin Newburn
Tiffany Sellaro
Jonathan Klein
Brian Caveney
Marcia Eisenberg

Frontiers in Oncology

doi 10.3389/fonc.2025.1565872

111 views

Case Report

Published on 17 Feb 2025

Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review

in Cancer Molecular Targets and Therapeutics

Wenjing Yang
Lin Shi
Hao Wang
Ying Li
Xingyu Ji
Hongjin Li
Guowang Yang
Weiru Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1481244

222 views

Original Research

Accepted on 14 Feb 2025

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

in Cancer Molecular Targets and Therapeutics

Bowen Wang
Mengjia Peng
Yan Li
Jinhang Gao
Tao Chang

Frontiers in Oncology

doi 10.3389/fonc.2025.1554242

Review

Published on 14 Feb 2025

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

in Cancer Molecular Targets and Therapeutics

Yi Ding
Qin Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1456959

223 views

Original Research

Published on 14 Feb 2025

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

in Cancer Molecular Targets and Therapeutics

Jian-Hao Zheng
Ding Shi
Yun-Jie Chen
Jian-Ping Liu
Zheng Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1544173

180 views

Brief Research Report

Accepted on 13 Feb 2025

Mapping MAGE-A4 Expression in Solid Cancers for Targeted Therapies Running header: Mapping MAGE-A4 expression in solid cancers Authors

in Cancer Molecular Targets and Therapeutics

Christin Habigt
Sylvie Rottey
Iben Spanggaard
Juanita Lopez
Elena Garralda
Emiliano Calvo
Oliver Bechter
Jayesh Desai
Rachel Galot
Leena Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2025.1484182

Retraction

Accepted on 12 Feb 2025

Retraction: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2025.1575643

Retraction

Accepted on 12 Feb 2025

Retraction: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2025.1575634

Original Research

Accepted on 12 Feb 2025

Prognostic value of CA125 in diffuse large B-cell lymphoma

in Cancer Molecular Targets and Therapeutics

Xiaohong Xu
Jie Zhang
Yijing Jiang
Long Chen
Linyan Xu
Bojian Ge
Xiaobing Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1548399

Original Research

Published on 12 Feb 2025

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

in Cancer Molecular Targets and Therapeutics

Jiaxing Zhang
Gang Wang
Jie Liu
Futian Tang
Song Wang
Yumin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1513622

254 views

Review

Published on 12 Feb 2025

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

in Cancer Molecular Targets and Therapeutics

Hao Tian
Qin Luo
Liuyang Huang
Guang Chen
Mingsheng Sun
Fanrong Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1527331

280 views

Review

Published on 12 Feb 2025

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

in Cancer Molecular Targets and Therapeutics

Lili Wang
Min Zhang
Kelei Zhao
Xiaohan Yuan
Houyu Zhao
Yanting Liu
Yinghua Ji
Ping Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1451130

181 views

Original Research

Accepted on 11 Feb 2025

The efficacy and safety of 225 Ac-PSMA-617 in metastatic castration-resistant prostate cancer

in Cancer Molecular Targets and Therapeutics

Jiao Ma
Yu Zhang
Jiangchu Yangqing
Guangfu Liu
Junzheng Wang
Chunyin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1516860

Navigation group

Articles

Exploring Therapeutic Applications of PTEN, TMPRSS2: ERG Fusion, and Tumour Molecular Subtypes in Prostate Cancer Management

Editorial: Molecular Mechanisms and Therapeutic Targets of Cancer Metastasis and Therapy Resistance

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies 1

From Tissue-Specific to Tissue-Agnostic: HER2 Overexpression and the Rise of Antibody-Drug Conjugates

Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review

Developing a predictive model and uncovering immune influences on prognosis for brain metastasis from lung carcinomas

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma

Develop a prognostic and drug therapy efficacy prediction model for hepatocellular carcinoma based on telomere maintenance-associated genes

Mapping MAGE-A4 Expression in Solid Cancers for Targeted Therapies Running header: Mapping MAGE-A4 expression in solid cancers Authors

Retraction: Corrigendum: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/b-Catenin Signaling Pathway Activation

Retraction: Upregulation of CCT-3 Induces Breast Cancer Cell Proliferation Through miR-223 Competition and Wnt/β-Catenin Signaling Pathway Activation

Prognostic value of CA125 in diffuse large B-cell lymphoma

ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation

Exploration of the quantitative-effectiveness association between acupuncture temporal parameters and chemotherapy-induced peripheral neuropathy in cancer patients: a dose-response meta-analysis of randomized controlled trials

The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes

The efficacy and safety of 225 Ac-PSMA-617 in metastatic castration-resistant prostate cancer